« Back to Record
de Azambuja, E., Agostinetto, E., Procter, M., Eiger, D., Pondé, N., Guillaume, S., Parlier, D., Lambertini, M., Desmet, A., Caballero, C., Aguila, C., Jerusalem, G., Walshe, J. M., Frank, E. E., Bines, J., Loibl, S., Piccart-Gebhart, M., Ewer, M., Dent, S., Plummer, C. J. C., & Suter, T. (2023). Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial. ESMO Open, 8(1), 100772. doi:10.1016/j.esmoop.2022.100772
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/372023



